Gastroprotective Effect of Cochinchina momordica Seed Extract in Nonsteroidal Anti-Inflammatory Drug-Induced Acute Gastric Damage in a Rat Model
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The major compounds of Cochinchina momordica seed extract (SK-MS10) include momordica saponins. We report that the gastroprotective effect of SK-MS10 in an ethanol-induced gastric damage rat model is mediated by suppressing proinflammatory cytokines and downregulating cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LOX), and the activation of calcitonin gene-related peptide. In this study, we evaluated the gastroprotective effects of SK-MS10 in the nonsteroidal anti-inflammatory drug (NSAID)-induced gastric damage rat model. Methods: The pretreatment effect of SK-MS10 was evaluated in the NSAID-induced gastric damage rat model using aspirin, indomethacin, and diclofenac in 7-week-old rats. Gastric damage was evaluated based on the gross ulcer index by gastroenterologists, and the damage area (%) was measured using the MetaMorph 7.0 video image analysis system. Myeloperoxidase (MPO) was measured by enzyme-linked immunosorbent assay, and Western blotting was used to analyze the levels of cyclooxygenase (COX)-1, COX-2, cPLA2, and 5-LOX. Results: All NSAIDs induced gastric damage based on the gross ulcer index and damage area (p<0.05). Gastric damage was significantly attenuated by SK-MS10 pretreatment compared with NSAID treatment alone (p<0.05). The SK-MS10 pretreatment group exhibited lower MPO levels than the diclofenac group. The expression of cPLA2 and 5-LOX was decreased by SK-MS10 pretreatment in each of the three NSAID treatment groups. Conclusions: SK-MS10 exhibited a gastroprotective effect against NSAID-induced acute gastric damage in rats. However, its protective mechanism may be different across the three types of NSAID-induced gastric damage models in rats.
Abstract
Background/Aims: The major compounds of Cochinchina momordica seed extract (SK-MS10) include momordica saponins. We report that the gastroprotective effect of SK-MS10 in an ethanol-induced gastric damage rat model is mediated by suppressing proinflammatory cytokines and downregulating cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LOX), and the activation of calcitonin gene-related peptide. In this study, we evaluated the gastroprotective effects of SK-MS10 in the nonsteroidal anti-inflammatory drug (NSAID)-induced gastric damage rat model. Methods: The pretreatment effect of SK-MS10 was evaluated in the NSAID-induced gastric damage rat model using aspirin, indomethacin, and diclofenac in 7-week-old rats. Gastric damage was evaluated based on the gross ulcer index by gastroenterologists, and the damage area (%) was measured using the MetaMorph 7.0 video image analysis system. Myeloperoxidase (MPO) was measured by enzyme-linked immunosorbent assay, and Western blotting was used to analyze the levels of cyclooxygenase (COX)-1, COX-2, cPLA2, and 5-LOX. Results: All NSAIDs induced gastric damage based on the gross ulcer index and damage area (p<0.05). Gastric damage was significantly attenuated by SK-MS10 pretreatment compared with NSAID treatment alone (p<0.05). The SK-MS10 pretreatment group exhibited lower MPO levels than the diclofenac group. The expression of cPLA2 and 5-LOX was decreased by SK-MS10 pretreatment in each of the three NSAID treatment groups. Conclusions: SK-MS10 exhibited a gastroprotective effect against NSAID-induced acute gastric damage in rats. However, its protective mechanism may be different across the three types of NSAID-induced gastric damage models in rats.
참고문헌 (36)
- Allen A, "Gastroduodenal mucosal protection", Physiol Rev, 73, pp.823~857 (1993)
- Flemstrom G, "Gastroduodenal HCO3(-) transport: characteristics and proposed role in acidity regulation and mucosal protection", Am J Physiol, 242, pp.G183~G193 (1982)
- Arakawa T, "15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications", Dig Dis Sc, 50(Suppl 1), pp.S3~S11 (2005)
- McCarthy DM, "Adverse effects of proton pump inhibitor drugs: clues and conclusions", Curr Opin Gastroenterol, 26, pp.624~631 (2010)
- Beck PL, "Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice", Gastroenterology, 119, pp.699~705 (2000)
- Yoshikawa T, "Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats", Gut, 34, pp.732~737 (1993)
- Yoshida N, "Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury", Dig Dis Sci, 40, pp.2300~2304 (1995)
- Takeuchi K, "Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility", Dig Dis Sci, 49, pp.180~187 (2004)
- Tanaka J, "Mechanism of superoxide generation system in indomethacin-induced gastric mucosal injury in rats", Biol Pharm Bull, 24, pp.155~158 (2001)
- Okada A, "Rat gastric mucosal cells express ICAM-1 and proinflammatory cytokines during indomethacin-induced mucosal injury", J Lab Clin Med, 131, pp.538~547 (1998)
- Arakawa T, "Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing", Dig Dis Sci, 43(9 Suppl), pp.5S~13S (1998)
- Choi SM, "Gastroprotective effects of DA-6034, a new flavonoid derivative, in various gastric mucosal damage models", Dig Dis Sci, 52, pp.3075~3080 (2007)
- Matsuda H, "Protective effects of oleanolic acid oligoglycosides on ethanol- or indomethacin-induced gastric mucosal lesions in rats", Life Sci, 63, pp.PL245~PL250 (1998)
- Kang JM, "Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)", 5-LOX pathway, 2009, pp.54, 2549~2560
- Pyoung Ju Seo, "Comparison of Indomethacin, Diclofenac and Aspirin-Induced Gastric Damage according to Age in Rats", Gut and Liver, 6(2), pp.210~217 (2012), 거트앤리버 발행위원회[DOI]
- Choi KS, "Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2", 5-lipoxygenase and activating gamma-glutamylcysteine synthetase, 2012, pp.27(Suppl 3), 13~22
- Ichikawa T, "CGRP modulates mucin synthesis in surface mucus cells of rat gastric oxyntic mucosa", Am J Physiol Gastrointest Liver Physiol, 279, pp.G82~G89 (2000)
- Lambrecht N, "Role of calcitonin gene-related peptide and nitric oxide in the gastroprotective effect of capsaicin in the rat", Gastroenterology, 104, pp.1371~1380 (1993)
- Gyires K, "The effect of some anti-ulcer agents on the early vascular injury of gastric mucosa induced by ethanol in rats", Acta Physiol Hung, 73, pp.149~154 (1989)
- Szabo S, "Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat", Gastroenterology, 88(1 Pt 2), pp.228~236 (1985)
- Peskar BM, "Role of prostaglandins in gastroprotection", Dig Dis Sci, 43(9 Suppl), pp.23S~29S (1998)
- Buttgereit F, "Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors", Am J Med, 110(Suppl 3A), pp.13S~19S (2001)
- Suleyman H, "Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers", Inflammation, 33, pp.224~234 (2010)
- Simon LS, "Role and regulation of cyclooxygenase-2 during in flammation", Am J Med, 106(5B), pp.37S~42S (1999)
- Brzozowski T, "Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers", Microsc Res Tech, 53, pp.343~353 (2001)
- Gambero A, "Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol", Dig Dis Sci, 52, pp.425~433 (2007)
- Jang SW, "Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis", Int J Pharm, 356, pp.88~94 (2008)
- Graumlich JF, "Preventing gastrointestinal complications of NSAIDs. Risk factors, recent advances, and latest strategies", Postgrad Med, 109, pp.117~128 (2001)
- DeWitt DL, "PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs", Am J Med, 95(2A), pp.40S~44S (1993)
- Clària J, "Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions", Proc Natl Acad Sci U S A, 92, pp.9475~9479 (1995)
- Tanaka A, "Up-regulation of COX-2 by inhibition of COX-1 in the rat : a key to NSAID-induced gastric injury", Aliment Pharmacol Ther, 16(Suppl 2), pp.90~101 (2002)
- DiJoseph JF, "Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity", J Pharmacol Exp Ther, 241, pp.97~102 (1987)
- Zayachkivska OS, "Gastroprotective effects of flavonoids in plant extracts", J Physiol Pharmacol, 56(Suppl 1), pp.219~231 (2005)
- Chatterjee A, "Biphasic effect of phyllanthus emblica L. extract on NSAID-induced ulcer: an antioxidative trail weaved with immunomodulatory effect", Evid Based Complement Alternat Med, 2011, pp.146808~ (2011)
- Hsu DZ, "Sesamol attenuates diclofenac-induced acute gastric mucosal injury via its cyclooxygenase-independent antioxidative effect in rats", Shock, 30, pp.456~462 (2008)
- Blandizzi C, "Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage", World J Gastroenterol, 11, pp.4052~4060 (2005)
